---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-087276"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2024-07-29T23:59:59+00:00"
generated_at: "2026-05-31T15:53:23.628817+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health appoints John Ragard to Board of Directors

## Summary
- John Ragard appointed to board effective July 25, 2024; designated by stockholder Jack W. Schuler.
- Ragard brings over 46 years of venture capital and public equity investment experience.
- Currently Senior Investment Advisor at Wayve Capital; previously managed portfolios at Spouting Rock and Friess Associates.
- Will serve as director until the company's 2025 annual meeting of stockholders.

## SEC filing metadata
- accession: 0000950170-24-087276
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2024-07-29T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000095017024087276/0000950170-24-087276-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000095017024087276/awh-20240725.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-087276
- JSON: https://secwatch.observer/filing/0000950170-24-087276.json
- Plain text: https://secwatch.observer/filing/0000950170-24-087276.txt

## Key facts
- Executive change
  John Ragard was appointed as director at Aspira Women's Health Inc..
  - Action: appointed
  - Role: director
  source text: On July 29, 2024, Aspira Women’s Health Inc. (the “Company”) issued a press release announcing the appointment of John Ragard as a director, effective July 25, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000095017024087276/0000950170-24-087276-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
